KGL PHALAENOPSIS & BREEDING ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.7% 10.3% 17.1% 13.8% 9.1%  
Credit score (0-100)  25 26 10 17 27  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  177 575 -35.7 168 386  
EBITDA  29.5 256 -350 63.9 249  
EBIT  -140 86.7 -561 63.9 249  
Pre-tax profit (PTP)  -139.4 86.7 -561.1 51.9 228.0  
Net earnings  -110.0 66.2 -514.6 51.9 228.0  
Pre-tax profit without non-rec. items  -139 86.7 -561 51.9 228  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  77.8 144 -371 -319 -90.7  
Interest-bearing liabilities  595 560 585 530 354  
Balance sheet total (assets)  1,750 2,655 2,065 1,449 769  

Net Debt  204 392 127 340 -122  
 
See the entire balance sheet

Volume 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  177 575 -35.7 168 386  
Gross profit growth  0.0% 224.8% 0.0% 0.0% 129.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,750 2,655 2,065 1,449 769  
Balance sheet change%  0.0% 51.7% -22.2% -29.8% -46.9%  
Added value  29.5 255.7 -349.7 275.2 248.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  211 -338 -423 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 1.0 2.0  

Profitability 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -78.8% 15.1% 1,571.8% 38.1% 64.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -8.0% 3.9% -22.0% 3.0% 18.9%  
ROI %  -18.4% 11.5% -84.0% 11.5% 56.3%  
ROE %  -141.4% 59.7% -46.6% 3.0% 20.6%  

Solidity 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12
Equity ratio %  4.4% 5.4% -15.2% -18.0% -10.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  693.0% 153.5% -36.3% 531.6% -49.0%  
Gearing %  764.9% 388.6% -157.9% -166.3% -389.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 2.2% 4.7%  

Liquidity 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12
Quick Ratio  0.8 1.0 0.8 0.8 0.9  
Current Ratio  0.9 1.0 0.8 0.8 0.9  
Cash and cash equivalent  390.7 167.1 458.3 190.2 475.6  

Capital use efficiency 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -218.8 -20.8 -370.6 -318.7 -90.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  29 256 -350 275 249  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  29 256 -350 64 249  
EBIT / employee  -140 87 -561 64 249  
Net earnings / employee  -110 66 -515 52 228